CGH
BHC icon

Crossmark Global Holdings’s Bausch Health BHC Stock Holding History

Crossmark Global Holdings’s Portfolio BHC Stock Details BHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-28,708
Closed -$240K – 1243
2022
Q2 		$240K Buy
28,708
+570
+2% +$7.97K 0.01% 1142
2022
Q1 		$643K Buy
28,138
+180
+0.6% +$4.4K 0.01% 802
2021
Q4 		$772K Buy
27,958
+3,830
+16% +$103K 0.02% 726
2021
Q3 		$672K Buy
24,128
+930
+4% +$26.4K 0.02% 773
2021
Q2 		$680K Sell
23,198
-870
-4% -$26.4K 0.02% 763
2021
Q1 		$764K Sell
24,068
-2,576
-10% -$75.6K 0.02% 701
2020
Q4 		$554K Buy
26,644
+1,820
+7% +$33.9K 0.01% 802
2020
Q3 		$386K Buy
24,824
+360
+1% +$6.2K 0.01% 896
2020
Q2 		$447K Buy
24,464
+540
+2% +$9.52K 0.01% 805
2020
Q1 		$371K Buy
23,924
+3,140
+15% +$75.7K 0.01% 760
2019
Q4 		$622K Buy
20,784
+620
+3% +$16.1K 0.02% 707
2019
Q3 		$441K Sell
20,164
-2,103
-9% -$48.1K 0.01% 841
2019
Q2 		$562K Buy
22,267
+30
+0.1% +$712 0.02% 761
2019
Q1 		$549K Buy
22,237
+1,360
+7% +$32.5K 0.02% 770
2018
Q4 		$386K Sell
20,877
-2,432
-10% -$57.9K 0.01% 896
2018
Q3 		$598K Buy
23,309
+3,621
+18% +$82.9K 0.02% 843
2018
Q2 		$458K Sell
19,688
-7,222
-27% -$149K 0.01% 1010
2018
Q1 		$428K Sell
26,910
-4,138
-13% -$77K 0.01% 1023
2017
Q4 		$645K Sell
31,048
-3,120
-9% -$49.5K 0.02% 825
2017
Q3 		$490K Buy
+34,168
New +$517K 0.01% 970
2016
Q3 		$490K Buy
+34,168
New +$884K 0.01% 970

Other funds holding BHC

IC
Icahn Carl Sunny Isles Beach, Florida $8.55B AUM 29.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.77B AUM 72.29% 1-Year Est. Return

Crossmark Global Holdings's BHC Position: Q3 2022 in Review

Crossmark Global Holdings sold out of Bausch Health (BHC) in Q3 2022, closing a stake of 28,708 shares — an estimated $240K sold.

Crossmark Global Holdings first reported a position in BHC in Q3 2016 and held it in 21 quarters. The position peaked at $772K in Q4 2021. 283 funds tracked by Wall St. Rank hold BHC as of Q3 2022.

  • Crossmark Global Holdings reported no remaining Bausch Health position as of Q3 2022 after selling out during the quarter.
  • Crossmark Global Holdings sold 28,708 Bausch Health shares in Q3 2022, an estimated $240K.
  • Crossmark Global Holdings first reported a position in Bausch Health in Q3 2016 and held it in 21 quarters.
  • Crossmark Global Holdings's Bausch Health position peaked at $772K in Q4 2021.
  • 283 funds tracked by Wall St. Rank held Bausch Health as of Q3 2022.

Based on Crossmark Global Holdings's 13F filing for Q3 2022, filed 1 Nov 2022.